Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Mar;28(3):1132-1139.
doi: 10.1007/s00330-017-5070-y. Epub 2017 Oct 6.

Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method

Ji Soo Song  1   2   3 , Eun Jung Choi  4   5   6 , Eun Hae Park  4   5   6 , Ju-Hyung Lee  7
Affiliations
Comparative Study

Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method

Ji Soo Song et al. Eur Radiol. 2018 Mar.

Abstract

Objectives: To compare the occurrence of transient severe motion (TSM) between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI and between gadoxetate disodium-enhanced MRI scans obtained with and without the application of a modified breath-holding technique.

Methods: We reviewed 80 patients who underwent two magnetic resonance examinations (gadoxetate disodium-enhanced MRI and gadopentetate dimeglumine-enhanced MRI) with the application of a modified breath-holding technique (dual group). This group was compared with 100 patients who underwent gadoxetate disodium-enhanced MRI without the application of the modified breath-holding technique (single group). Patient risk factors and motion scores (1 [none] to 5 [non-diagnostic]) for each dynamic-phase imaging were analysed.

Results: In the dual group, mean motion scores did not differ significantly between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI (p=0.096-0.807) in any phase. However, in all phases except the late dynamic phase, mean motion scores of the dual group were significantly lower than those in the single group. TSM incidence did not differ significantly between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI in the dual group (3.8% vs. 1.3%, p=0.620).

Conclusion: With proper application of the modified breath-holding technique, TSM occurrence with gadoxetate disodium-enhanced MRI was comparable to that associated with gadopentetate dimeglumine-enhanced MRI.

Key points: • The modified breath-holding method significantly reduced the incidence of TSM. • Gadoxetate disodium and gadopentetate dimeglumine showed comparable motion scores. • TSM incidence was comparable between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI.

Keywords: Arterial phase; Gadopentetate dimeglumine; Gadoxetate disodium; Magnetic resonance imaging; Motion artefact.

PubMed Disclaimer

References

    1. Radiology. 2016 Apr;279(1):93-102 - PubMed
    1. Abdom Radiol (NY). 2017 Oct;42(10 ):2393-2401 - PubMed
    1. J Clin Oncol. 2011 Sep 20;29(27):3643-50 - PubMed
    1. J Magn Reson Imaging. 2013 Feb;37(2):398-406 - PubMed
    1. AJR Am J Roentgenol. 2014 Oct;203(4):796-802 - PubMed

Publication types

LinkOut - more resources